Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus With Diabetic Nephropathy”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Not applicableLooking for participantsNCT07485075
What this trial is testing

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Who this might be right for
Diabetes Type 2Kidney Disease
Steno Diabetes Center Copenhagen 104
Testing effectiveness (Phase 2)Study completedNCT06051565
What this trial is testing

Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients

Who this might be right for
DiabetesMagnetic Resonance Imaging
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 12
Post-approval studies (Phase 4)WithdrawnNCT03504566
What this trial is testing

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

Who this might be right for
Diabetic Nephropathy Type 2
Steno Diabetes Center Copenhagen
Large-scale testing (Phase 3)Study completedNCT03436693
What this trial is testing

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 308
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Not applicableStudy completedNCT03889236
What this trial is testing

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Who this might be right for
Diabetic Nephropathy Type 2AlbuminuriaType2 Diabetes Mellitus+7 more
Leiden University Medical Center 56
Post-approval studies (Phase 4)Study completedNCT06224790
What this trial is testing

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Diabetic NephropathiesType 2 Diabetes
Sidrah Lodhi 60
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT01968668
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Who this might be right for
Diabetic Nephropathies
Bayer 96
Testing effectiveness (Phase 2)Study completedNCT05718375
What this trial is testing

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Who this might be right for
Diabetic Nephropathies
Curacle Co., Ltd. 240
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Testing effectiveness (Phase 2)Study completedNCT03620773
What this trial is testing

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesityBariatric Surgery Candidate+9 more
University of Colorado, Denver 24
Not applicableStudy completedNCT07555327
What this trial is testing

Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.

Who this might be right for
End-Stage Renal Disease (ESRD) Chronic Kidney Disease, Stage 5 Renal Regeneration Anuria Diabetic NephropathyAnuriaEnd-Stage Renal Disease (ESRD)+6 more
Amar h Zireg 8
Large-scale testing (Phase 3)Ended earlyNCT00120328
What this trial is testing

To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Speedel Pharma Ltd. 2,364
Not applicableStudy completedNCT03154398
What this trial is testing

Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.

Who this might be right for
Evaluation Thyroid Functions in Diabetic Patient
Assiut University 100
Not applicableLooking for participantsNCT02169518
What this trial is testing

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

Who this might be right for
Diabetes MellitusBariatric Surgery Candidate
Manchester University NHS Foundation Trust 600
Large-scale testing (Phase 3)Study completedNCT02065791
What this trial is testing

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathy
Janssen Research & Development, LLC 4,401
Testing effectiveness (Phase 2)Study completedNCT01053936
What this trial is testing

Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 129
Load More Results